Background-Identity-by-descent mapping using empirical estimates of identity-by-descent allele sharing may be useful for studies of complex traits in founder populations, where hidden relationships may augment the inherent genetic information that can be used for localization. Methods and Results-Through identity-by-descent mapping, using ≈400 000 single-nucleotide polymorphisms (SNPs), of serum lipid profiles, we identified a major linkage signal for triglycerides in 1007 Pima Indians (LOD=9.23; P=3.5×10
G enome-wide association studies (GWASs) of unrelated individuals have become popular approaches for identifying susceptibility genes for complex traits. A well-known drawback is that they require very large samples to detect the modest effect sizes often associated with single variants; furthermore, relevant functional variants must be well captured by the genotyping platform. Analyses of related individuals can have advantages over those of unrelated individuals because they allow for the efficient detection of high-impact variants with a relatively small sample size and increased power for follow-up association studies. 1 Linkage studies, which analyze phenotypic similarity among related individuals with respect to identity by descent (IBD) in a given region, may efficiently detect regions which contain multiple functional variants, and they do not require functional variants to be highly concordant with genotyped markers. However, conventional linkage studies have been limited by only analyzing allele sharing among individuals with known relationships. In recent years, methods have been developed to improve calculation of sharing of alleles IBD from dense genotypic data. These methods allow for the IBD calculation among individuals without known relationships (ie, they are cryptically related). With this approach, one may considerably improve the efficiency of variance component IBD mapping (also known as populationbased linkage analysis). This approach may be particularly appealing for studies in founder populations, as members of such populations tend to share longer chromosomal segments IBD with one another. 2 In this study, we performed a population-based genome-wide linkage study (GWLS) of serum APOC3/APOA5 as a Major Lipid Locus lipid levels in 1024 individuals from a founder population, the Pima Indians residing in the United States, who had previously participated in a GWAS. 3 We were able to pinpoint specific functional variants explaining a very significant linkage signal for serum triglycerides through a 4-stage study, including a GWLS, fine-mapping analyses, replication association studies, and the fitting of a final linkage and association model.
Methods

Study Populations
Much of the data were derived from a longitudinal community-based cohort study of type 2 diabetes mellitus conducted in Arizona, where most of the participants are Pima Indians (the Pima study). 4 For the initial discovery involving GWLS, 1024 Pima subjects, who had also participated in a GWAS 3 with available lipid data, including total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, and low-density lipoprotein cholesterol measurements, were included (1007 had triglyceride measurements).
The first sample for replication studies included 5491 (4668 with triglyceride data) additional Pima subjects who were not part of the initial discovery set and did not have GWAS data. Among these participants, 2713 are full-heritage Pima Indians (defined as self-reported 8/8th Pima heritage) and another 2778 subjects are, on average, 6/8th American Indian (typically 4/8th Pima and an additional 2/8th from other tribes). A subset of the Pima participants (n=296) had whole-genome sequence (WGS) data available, which were used to profile the genomic variations in this population.
A second set of samples for the replication studies came from the Phoenix extension of FIND (Family Investigation of Nephropathy and Diabetes), a multicenter study designed to identify genes involved in diabetic nephropathy and related traits. Eligible subjects (n=3189; 2793 with triglyceride data) had ≥50% Amerindian heritage, and most were urban-dwelling Amerindians living in or near Phoenix. Table I in the Data Supplement shows characteristics of these 3 groups. Studies were approved by the Institutional Review Board of the National Institute of Diabetes and Digestive and Kidney Diseases, and all participants provided written informed consent. Phenotypic measurements were based on standard protocols and are described in the Data Supplement.
Genotypic Data Ascertainment
Genotypes used in the linkage analysis (to calculate IBD sharing in the autosomal genome and to assess local IBD) were produced with the Affymetrix 6.0 Human single-nucleotide polymorphism (SNP) Array (Methods in the Data Supplement). A total of 398 430 autosomal SNPs passed quality control checks and were used in subsequent analyses. As part of our fine-mapping studies, we used WGS data of 296 Pima Indians for variant discovery and imputation. The WGS data were generated by Illumina (San Diego, CA) at a coverage of 30 to 40×.
Genotyping of SNPs in both replication sets used a variety of genotyping approaches, which are described in detail in the Data Supplement. In addition, 45 selected ancestry informative markers with large differences in allele frequency between Amerindian and European populations 5 were genotyped and used to control for population admixture in replication samples, in which GWAS data were not available.
Statistical Analyses
Estimation of the Percentage of Alleles Shared IBD
The execution of variance components linkage analysis of quantitative traits requires information on the alleles shared IBD between 2 individuals. We used the program Beagle 6 and genetic maps from the Hapmap project to perform IBD estimation at each of ≈400 000 SNPs; this program estimates IBD from haplotypic similarity based on a hidden Markov model that takes recombination and linkage disequilibrium (LD) among SNPs into account. More details on the parameter settings and calculation are provided in the Data Supplement.
GWLS of 4 Lipid Traits
All traits were normalized by inverse Gaussian transformation before analysis. Linkage analysis was conducted using the principles of the variance components method developed by Amos 7 and performed using SAS (SAS Institute, Cary, NC; Methods in the Data Supplement). For computational efficiency, we performed linkage analysis at every 50th variant across the genome, after which the maximum logarithm of the odds for linkage (max LOD) was determined. In other words, ≈8000 tests (at ≈0.44 cM intervals) were performed.
Because we used the IBD matrix generated from the Beagle estimates among all 523 776 pairs of individuals in the sample, instead of those from known relationships, the present study is termed a population-based linkage analysis.
Fine-Mapping Study: Association Analysis Conditional on Linkage Effects
To identify whether association with specific genetic variant(s) may explain the observed linkage signals, we performed association analyses conditional on linkage effects (ie, accounting for random effects of both local and global IBD) to evaluate the association of variants under the linkage peak in the 1024 subjects used in linkage analyses. The region of interest was defined as the 2-LOD support interval (ie, the interval in which the LOD is within 2 U of the max LOD). Sources of genotypic data used in these analyses are described in the Data Supplement. To account for the relatedness among family members in the analyses, we used the measured genotype approach, 8 in which the genotypic effects are incorporated as fixed effects in the mixed model. In an effort to identify genetic variants with distinct effects, variant(s) with stronger association(s) were included as covariate(s) in the next round of analysis, until no significant association was observed (ie, P value <0.05 corrected for multiple comparisons; Methods in the Data Supplement).
Replication Association Analyses of Triglycerides
Replication studies were performed in 2 stages. First, we conducted the replication study in Pima Indians (the Pima sample; n=4668 after exclusion of those in the GWLS). If any associations were replicated, we conducted a second replication study using 2793 Amerindian samples from FIND). Detailed statistical approaches and meta-analysis methods are described in the Data Supplement. Because variants examined were from a small region of the genome with a high density of variants where extensive LD was present, we corrected for multiple comparisons using the approach suggested by Moskvina and Schmidt 9 (more details in the Data Supplement). All presented P values for the fine-mapping and replication studies are corrected P values.
Haplotype Construction and Analyses
Once we identified multiple variants within a small gene with strong association with triglycerides, we performed haplotype analysis to assess associations conditional on specific allelic backgrounds constituting ≥2 SNPs (Data Supplement).
Covariates (population admixture estimates, type 2 diabetes mellitus status, and sex) used in all models are described in the Data Supplement. Population admixture estimates used in the linkage studies were obtained using principal components analysis, and those used in the replication studies were calculated as Amerindian heritage based on 45 ancestry informative markers. Details are described in the Data Supplement.
Results
Empirical IBD Estimates
Among the 1024 subjects in the GWLS, the average estimated IBD across the genome ranged from 0.00001 to 0.57 for 523 776 pairs of subjects. Pairs with no known relationship (98.2% of all pairs) had a mean IBD of 0.02±0.01 (median=0.02). In contrast, the mean IBD for 171 pairs of individuals of white ethnicity genotyped with the same SNP array was 0.0009±0.0007 (median=0.0008), suggesting that average relatedness among Pimas was much greater. A plot showing the estimated empirical IBD sharing by the expected relatedness is shown in the Figure I in the Data Supplement.
Genome-Wide Linkage Studies
Among 4 lipid traits analyzed, significant linkage (max LOD≥3) was identified for triglycerides and HDL-C. The max LOD for triglycerides was 9.23 (P=3.5×10 −11 ) on chromosome 11q23, explaining 10.6% of phenotypic variance (after accounting for effects of covariates), and the max LOD for HDL-C was 3.77 (P=1.5×10 −5 ) on chromosome 1p, explaining 7.5% of the variance (Table II and Figure II in the Data Supplement). When the same analysis was conducted using only pairs with known selfreported relationships (n=9664), the max LOD for triglycerides was still observed in the same genomic region, however, with a much-reduced significance (LOD=3.24; P=5.6×10 −5 ; Figure 1A) . A similar reduction in LOD was observed for HDL-C, and the max LOD was 2.55 ( Figure 1B ). We further refined the location of the max LOD by running additional linkage analyses at 5-SNP intervals within the 2-LOD region. This resulted in max LOD of 9.32 (explaining 10.8% of the variance) and 4.05 (explaining 7.9% of the variance), for triglycerides and HDL-C, respectively. These refined max LOD locations were used to define genomic regions investigated in subsequent fine-mapping studies.
We also conducted a GWAS of these traits in the same sample and observed associations for triglycerides with SNPs in 11q23 at genome-wide significance ( Figure III in the Data Supplement). The strongest association was with rs4417316, an intronic SNP in ZPR1 (P=1.8×10 −10 ), but rs964184, the most commonly reported GWAS SNP for triglycerides observed in multiple populations, also was strongly associated (P=4.0×10 −8 ). The associations of all SNPs in this region were attenuated to P >10 −5 after adjusting for the effects of rs964184. Thus, it seemed that the GWAS associations in Pimas largely reflected the effect of the established SNP rs964184. In contrast, linkage analyses of triglycerides conditional on the effect of rs964184 or rs4417316 showed significant residual effect (LOD=6.02 and 4.80, respectively), suggesting the possibility of multiple variants in the region.
Fine-Mapping Study: Association Analyses of Triglycerides and HDL Conditional on Linkage Effect
We performed imputation, using WGS data from 296 Pimas as the reference, and we conducted fine mapping of the 2-LOD support interval for both regions by testing association conditional on the peak linkage signal in the same 1024 samples used in GWLS. We selected the variant with the strongest association and analyzed associations of additional variants conditional on this strongest association; this procedure was repeated until no statistically significant associations were observed. For triglycerides, after 4 rounds of analyses of 3450 variants in a 1.81 Mb region on 11q23, we identified 3 variants with distinct and significant associations ( Table 1 ). The SNP with the strongest association with triglycerides was rs147210663 explaining 6.9% of the variance (P=1.6×10 −13 ; Table 1 ). This SNP is in the apolipoprotein C3 gene (APOC3) at codon 43 (Ala→Thr substitution, or A43T); the minor allele codes for 
APOC3/APOA5 as a Major Lipid Locus
the Thr residue and has a frequency of 2.6% in GWLS. The SNP with the second strongest association with triglycerides was rs2072560 after adjusting for the effect of rs147210663 (P=0.00028). This SNP resides in intron 3 of the apolipoprotein A5 gene (APOA5) but has no known function. The third variant with a significant association was rs11357208 after adjusting for the effects of 2 previous SNPs (P=0.0049). This insertion-deletion variant resides in intron 5 of the SIK family kinase 3 gene (SIK3) without any known function. For HDL-C, no significant association was identified with any variant in the 2-LOD support interval on chromosome 1p.
Replication Association Analyses of Triglycerides
To confirm and further characterize the associations identified in the fine-mapping study, we analyzed the 3 distinctly associated triglyceride variants, along with their tags (r 2 >0.8 in Pima WGS data) and nearby established triglycerideassociated SNPs selected from published data. These studies were conducted in 2 different samples, namely (1) additional Pimas from the same parent study who were not part of GWLS (n=4668; the Pima sample) and (2) southwestern urban Amerindians from the FIND sample (n=2793). We, thus, analyzed 11 SNPs, including 6 established triglycerideassociated SNPs (collectively called GWAS SNPs, including rs964184, rs3135506, rs651821, rs662799, rs12225230, and rs139961185). [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] As shown in Table 1 , there was no tag SNP for rs147210663 nor rs11357208. The SNP rs2072560 had 3 tag SNPs (one of them, rs651821, was also identified in several published GWAS reports). As in the fine-mapping study, several rounds of analysis were conducted, with association examined conditional on the strongest variants identified in previous rounds. In the Pima sample, the association with the APOC3 A43T SNP strongly replicated (rs147210663; P=7.4×10 −48 ), as did the second variant (represented by rs651821; P=0.0012; Table 2; Table III in the Data Supplement). In addition, we also observed a strong association with a GWAS SNP (rs964184, P=2.1×10 −22 ) distinct from rs147210663. The variant rs11357208 did not show an association distinct from rs147210663, rs964184, and rs651821. However, as rs964184 was in moderate LD with both rs651821 and rs11357208 (r 2 =0.20 and 0.45, respectively), this may partially explain the lack of replicated association with rs11357208. In the second replication study (the FIND sample), we also observed distinct associations with rs964184 (1.4×10 −10 ) and rs147210663 (P=6.3×10 −7 ). Of note, the frequency of the Thr allele of rs147210663 in the FIND sample was much lower than that in the Pima sample (1% versus 2.5%). Taken together, we replicated 2 distinct associations (with rs147210663 and rs964184).
Determining Whether Known Functional Variants Account for the Observed Association With rs964184
The GWAS SNP rs964184 resides near the 3′untranslated region (UTR) of the zinc finger gene (ZPR1, also known as ZNF259), identified from fine-mapping analyses) harbor 2 genes: ZPR1 and APOA5. APOA5 is expressed solely in liver tissues, the key organ for lipid metabolism, whereas ZPR1 is expressed ubiquitously. APOA5 has a known role in triglyceride metabolism and has an SNP (rs651821) significantly associated with triglycerides. Therefore, we extended our association study to investigate whether other functional variants in these 2 genes may explain the observed association with rs964184. On the basis of Pima WGS data, 4 SNPs in APOA5 were previously documented to be functional [20] [21] [22] [23] with a minor allele frequency ≥1%: rs2266788, rs3135506, rs651821, and rs662799. We tested associations between triglycerides and these SNPs to examine the extent to which they explained the association of rs964184 with triglycerides. As shown in Figure 2 , in the Pima sample, rs964184 (dark bars) accounted for 2.2% of the trait variance with P value of 5.7×10 −23 when no APOA5 SNP was included in the model (conditioning on the effect of rs147210663 and other covariates). This effect was gradually diminished with the addition of more APOA5 SNPs. When 3 APOA5 SNPs (rs651821, rs3135506, rs2266788) were included, they accounted for 2.4% of the variance (P=1.2×10 −22 ) collectively, whereas the effect of rs964184 was reduced to 0.07% (P=0.015). The addition of rs662799 (r 2 =0.96 with rs2266788) did not contribute significantly beyond other APOA5 SNPs. We also conducted similar analyses of all SNPs in the exons or UTRs of ZPR1 (rs61905116, rs144966144, and rs35120633, identified in our Pima WGS data). The effects of rs964184 on triglycerides remained highly significant after adjusting for all 3 SNPs. In addition, although our study populations had a high type 2 diabetes mellitus prevalence, the genetic associations with these SNPs in APOC3 and APOA5 were observed in those with or without diabetes mellitus (data not shown). The exclusion of subjects taking antilipidemic medications (≈5%) from analyses did not affect any results significantly (data not shown).
Haplotype Analyses of APOA5 SNPs
Assessment of the distinct contribution of 3 APOA5 SNPs is difficult because they are in LD (r 2 =0.04-0.75; Figure IV in the Data Supplement), and their statistical associations may be codependent when their effects are assessed individually. Therefore, we performed analysis of haplotypes composed of these 3 SNPs to better evaluate allelic effects of each of these SNPs relative to the allelic background of other 2. Previous studies have described 3 common haplotypes at these SNPs: APOA5*1 containing the triglyceride-lowering allele at all 3 loci (T-Ser-A for rs2266788-rs3135506-rs651821), APOA5*2 containing the triglyceride-raising allele at rs2266788 and rs651821 (C-Ser-G), and APOA5*3 containing the triglyceride-raising allele only at rs3135506 (T-Trp-A). In East Asian populations, an additional haplotype (APOA5*4) containing only 1 triglyceride-raising allele (at rs651821, T-Ser-G) has been observed. 24 In the Pimas, we found that *1, *2, and *3 were common haplotypes, and we observed an additional haplotype with frequency of 3.6% which contains the triglyceride-raising allele at rs2266788 only (C-Ser-A, which we call APOA5*5). Given the same allelic background at the other 2 SNPs, distinct allelic effects of all 3 APOA5 SNPs were statistically significant (Table 3) . For instance, compared with the allelic background of rs2266788 and rs651821 (reference haplotype: APOA5*1), the APOA5*3 haplotype, which differs only at the minor allele of rs3135506, was still significantly associated with higher triglycerides (P=1.3×10 −12 ). Furthermore, compared with APOA5*1, APOA5*2, which differs at rs651821 and rs2266788, was associated with significantly higher triglycerides (P=2.2×10 −23 ). The haplotypic associations were replicated in the FIND sample with the exception of the comparison of APOA5*2 with APOA5*5, whose borderline significance was likely because of the low frequency of APOA5*5 (0.5%).
Final Linkage and Association Model Fitting
From replication studies, we identified the APOC3 A43T SNP (rs147210663) and 3 APOA5 SNPs (rs2266788, rs3135506, and rs651821), which are well established as functional, as having significant influences on triglycerides. Their effects all seemed additive (Figure V in the Data Supplement). Therefore, we included these 4 SNPs as covariates in the original linkage model (n=1007 Pimas) and assessed the extent to which these 4 SNPs explain the linkage signal. As shown in Table 4 , the APOC3 43T SNP alone reduces the LOD from 9.32 to 2.24. When we added 3 APOA5 SNPs to the model, the collective effect of these 4 SNPs reduced the remaining linkage signal to LOD of 0.08 (residual variance explained=1.4% after accounting for the effects of 4 SNPs and all covariates). In other words, these 4 SNPs virtually explained the linkage signal on 11q23 for triglycerides.
Discussion
Although GWAS in unrelated individuals has been successful in identifying common variants associated with complex traits, family-based studies, such as IBD mapping (linkage) analysis, may have advantages in some situations, such as when the functional variants are not well captured in the standard GWAS array. In this study, we used an IBD mapping approach in a founder population to identify genomic ) of triglycerides explained by rs964184 (black bars, conditional on any APOA5 SNPs) and the %σ 2 resulting from the addition of the APOA5 SNPs (gray bars) to the statistical model. Bottom, The significance of association (log(p)). Covariate effects adjusted included age, sex, diabetes mellitus status, and rs147210663 genotypes. The order of APOA5 SNP addition was determined by their association significance conditioning on effects of SNPs with stronger effects. The P values for the APOA5 SNP associations were calculated with the df equal to the number of SNPs in the model. APOC3/APOA5 as a Major Lipid Locus region(s) harboring substantial genetic effects on lipid levels. Estimating IBD empirically using dense genotypic data, we performed linkage analysis using all possible pairs within our study sample.
Using this approach, we identified a significant linkage signal with LOD of 9.23 for triglycerides in our GWLS. Through subsequent fine-mapping and 2 sets of replication studies, we identified 2 SNPs (rs147210663 and rs964184) with significant and distinct associations with triglycerides. One replicated SNP (rs964184) has no known function and is located near the 3′UTR of ZPR1. Little evidence has been found to indicate ZPR1 influence on lipid metabolism despite rs964184 being the most widely replicated GWAS SNP for triglycerides. Thus, we focused on variants in the only other candidate, APOA5. APOA5 variants have been extensively studied functionally because of the protein's importance in triglyceride metabolism. From Pima WGS data, we identified 4 SNPs in APOA5 with strong functional evidence from literature. We showed that the effect of rs964184 could be mostly explained by 3 of these APOA5 SNPs (the fourth SNP is in almost perfect LD with 1 of these 3). In other words, we consider it highly likely that rs964184 acts as a marker for the aggregate effect of these 3 SNPs with known effects on APOA5. Collectively, the APOC3 A43T SNP and the 3 strongly associated functional SNPs in APOA5 explained most of the linkage signal.
The APOC3 A43T SNP had the strongest association with triglycerides and had an effect size (β=−0.92±0.64 SD unit for the minor allele Thr, which corresponds to a 42% reduction in triglycerides) among the largest reported for any complex trait. 25 Its effect accounted for 4.7% of the variance of triglycerides despite a fairly low frequency of the Thr allele (2.5%) in Pimas. It was also significantly associated with other lipid traits and lipid fractions, including with higher HDL-C and lower triglycerides contained in very-low-density lipoprotein particles (Table III in the Data Supplement). The Thr allele is rare in most other populations, with a minor allele frequency of ≈1% in the other Southwest Amerindians, and very rare in most non-Amerindians with a collective frequency of 0.3% in phase 3 data from the 1000 Genomes Project (www.1000genomes. org). The A43T SNP was initially identified in 2 Mayan Indians with low triglycerides and APOC3 levels (where it was denoted as A23T). 26 Strong associations between triglycerides and rare nonsynonymous SNPs in APOC3 have been observed in other populations as well, with loss-of-function variants conferring lower triglyceride levels. Such an association was first suggested by a fine-mapping study following a GWAS in the Amish, 27 in whom a premature stop codon (R19X, rs76353203), which is rare in most populations, had frequency of 2.8% and was strongly associated with low triglyceride levels. This same SNP was also identified as strongly associated with low triglyceride levels in a Greek population isolate, in whom its frequency was 1.9%. 28 Subsequently, several large sequencing or candidate gene studies have also provided evidence for strong protective effects of loss-of-function mutations in APOC3 on triglycerides and cardiovascular diseases [28] [29] [30] [31] [32] [33] ; these variants included the A43T SNP but were tested for association in aggregate. The present study shows that the A43T SNP is relatively common in some Amerindian populations (particularly Pimas), among whom the association achieves genome-wide statistical significance.
APOC3 is a small gene with 4 exons and 297 nucleotides. The protein is synthesized mainly in the liver and strongly inhibits hepatic uptake of very-low-density lipoprotein cholesterol and intermediate-density lipoproteins. Intracellularly, it promotes hepatic very-low-density lipoprotein cholesterol assembly and secretion. 34 Extracellularly, it attenuates hydrolysis and clearance of triglyceride-rich lipoproteins and impairs the lipolysis of triglyceride-rich lipoproteins by inhibiting lipoprotein lipase 34 Recently, inhibitors of APOC3 synthesis have been shown to reduce hypertriglyceridemia. 35 The sequence of APOC3 has been extensively determined in large and diverse samples. In the Pimas, there is only 1 nonsynonymous SNP (A43T) identified in 296 samples. Findings from in vitro studies show that this A→T substitution probably alters the structure of APOC3 and leads to loss of its function in promoting the assembly and secretion of triglyceride-rich very-low-density lipoprotein from hepatic cells. 36 Also it has been shown that it has less efficient lipid-binding capacity; this leads to faster catabolism of APOC3 and less competition with APOE. This in turn is responsible for enhanced clearance of triglyceride-rich lipoproteins and lower plasma triglyceride levels. 26 Given all available statistical, functional, and physiological evidence, and the observation that the A43T SNP has no tag SNP, we consider that this SNP is likely a causal variant for triglycerides.
In our replication studies, the SNP with the second strongest association with triglycerides was rs964184. It is one of the most well-replicated SNPs from many large lipid GWAS, with particularly strong associations for triglycerides. 10, [12] [13] [14] [15] 19, 25, 37, 38 Previous studies in Amerindian-derived populations have identified strong associations between triglycerides and variants in this chromosomal region, particularly rs964184. 14, 19, 39 SIK3 has been suggested as a functional candidate based on evidence for recent natural selection centered on rs139961185. 19 In our study, however, rs139961185 was not associated with triglycerides after conditioning on rs964184 (Table III in the Data Supplement) . BUD13 and ZNF259 have also been implicated, based largely on the strong association with the nearby rs964184. 14, 39 The SNP rs964184 is also near APOA5, however, and 4 common APOA5 SNPs (rs2266788, rs3135506, rs651821, and rs6622799) have well-documented functional effects on APOA5. The only nonsynonymous SNP of these 4 is rs3135506 (S19W) which impairs protein translocation and secretion, 20, 21 whereas rs651821 is located in the promoter region, and rs2266788 is located in the 3′UTR of APOA5, a functional target site for a liver-expressed microRNA gene miR-485-5p. Our findings provided statistical evidence to implicate 3 functional SNPs (rs651821, rs3135506, and rs2266788) in APOA5 that explained almost all of the association of rs964184 with triglycerides, contributed distinct effects, and that reduced the original linkage signal to virtually null. It should be noted that our findings are in concordance with functional studies that suggest distinct effects of each of these SNPs (Table 3 ; Figure 2 ). These 3 APOA5 SNPs all have elevated minor allele frequencies in Pimas (0.14-0.20 versus 0.06-0.08 in whites), which resulted in increased statistical power in our study populations. One caveat is that as the fourth putatively functional SNP, rs6622799, is in almost perfect LD with rs2266788 (r 2 =0.96), their effects are not statistically distinguishable in our study populations.
Many studies have reported associations of haplotypes composed of these APOA5 functional variants with triglycerides. In 2001, Pennacchio et al 40 reported that the APOA5*2 haplotype, defined by the minor alleles of 3 SNPs (encompassing multiple functional variants rs662799-rs651821-rs2266788), was associated with elevated triglyceride levels, and similar observations were replicated in multiple populations. 24, [41] [42] [43] In some GWAS, these SNPs were individually reported as significant. 11, 17, 44 Our study identified these same SNPs in a systematic approach and provided additional support for multivariant influences from APOA5 on triglycerides. In vitro studies suggest that all 3 SNPs have functional effects, 22 but separate effects are difficult to observe in vivo because of the high degree of LD. With the additional haplotypic information available in the present study, we provide evidence for distinct effects of rs651821, rs3135506, and rs2266788/rs662799 on triglycerides in vivo, and associations with the haplotypes APOA5*2 and APOA5*3 (representing rs3135506) achieve genome-wide statistical significance. Although these 3 APOA5 SNPs were only in moderate LD with rs964184 individually (r 2 =0.25-0.40; Figure IV in the Data Supplement), the haplotypes comprised any minor (triglyceride-raising) allele of APOA5 SNPs were in strong LD with the minor allele of rs964184 collectively (r 2 =0.97; Figure  VI in the Data Supplement), and, thus, the APOA5 SNPs can largely account for the association of rs964184 with triglycerides in Amerindians. On the basis of analysis of data from the 1000 Genomes project (www.1000genomes.org), it is noteworthy that rs964184 is similarly highly concordant with haplotypes containing a triglyceride-raising allele at these APOA5 SNPs in populations representative of those where rs964184 was identified as a top GWAS SNP (eg, r 2 =0.96 in European ancestry in Utah and Gujarati Indian in Houston; r 2 =0.82 in Chinese in Beijing and Mexican ancestry in Los Angeles); thus, these APOA5 SNPs might explain the association between rs964184 and triglycerides in other populations as well. The role of APOA5 in influencing triglyceride levels is supported by recent human sequencing studies showing rare deleterious APOA5 mutations associated with triglycerides. 45 Given statistical, functional, and physiological evidence, we conclude that rs964184 is likely a marker for the collective effects of APOA5 functional SNPs on triglycerides.
The linkage analysis results provide a context for interrogating whether multiple sources of genetic effect exist in the same genomic region. In our GWAS using the same 1007 subjects, we observed associations for triglycerides with SNPs on 11q23 at genome-wide statistical significance, but these associations were greatly attenuated after adjustment for the established variant, rs964184. On the other hand, substantial residual linkage remained after adjustment for the effects of rs964184, and this served as the impetus for more detailed investigation of the region. Although computational tools for the IBD calculations required for population-based linkage analyses are available in several software packages, the method has not been widely used. Our results suggest that it can provide complementary information to a standard GWAS approach.
An advantage of the population-based linkage approach is that, in contrast to association analysis, it retains power even when the variants on the genotyping array are not highly concordant with a functional variant. The approach may be especially useful for identifying regions with susceptibility variants not well captured by the genotyping platform (which will often be of low frequency) or identifying regions containing multiple susceptibility variants. For the 11q23 region identified here as linked with triglycerides, both situations apply. The method uses information from all pairs of individuals in the population, and this remarkably enhances the statistical power, compared with conventional pedigree-based linkage analysis, particularly in populations recently descended from a small number of founders, in which many individuals without known relationships may share large genomic segments IBD. The approach may be less useful in outbred populations, however. Power of the linkage approach is limited, compared with conventional association analysis, in the situation where a single functional variant, which is well captured by the genotyping array, drives the association. A further limitation of the present study is that, with the limited sample size of GWLS, only relatively strong effect sizes are detectable; we estimate that the detectable effect size is 9.7% of the variance for LOD >3 with 80% power (our linkage signal for triglycerides had an effect size of 10.8% of the variance).
In conclusion, we performed a population-based GWLS of serum lipids and subsequently identified 4 SNPs with known functional effects in 2 apolipoprotein genes (APOC3 and APOA5) that influence triglyceride levels. These findings suggest that population-based GWLS may provide complementary information to GWAS, particularly in founder populations. Identification of the triglyceride-lowering nonsynonymous SNP in APOC3 (A43T) was facilitated by population-specific WGS data, which allowed for accurate imputation of this variant despite its low frequency, and the fact that it was not on the GWAS array (this SNP could not be captured by imputation using the 1000 Genome data as the reference panel). The APOC3 A43T SNP has been established as a loss-of-function variant leading to lower triglycerides based on a small number of previously described individuals and functional studies. By uncovering a founder effect in the Pimas for this SNP, we now provide population-level data that unequivocally establish the triglyceridelowering properties of this SNP. Thus, the linkage signal we detected represents effects of both an established triglyceride variant (rs964184) and a novel variant (A43T), not captured by standard GWAS arrays. We also provide evidence for 3 functional APOA5 SNPs exerting distinct and additive effects on triglycerides. The association between rs964184 and triglycerides has been replicated in multiple populations; our study demonstrates that rs964184 is likely a marker tagging aggregate effects of 3 functional SNPs in APOA5, at least in Amerindians. Thus, a single well-replicated GWAS signal can reflect the effects of multiple functional variants. Taken together, the APOC3 and APOA5 SNPs account for 6.9% of the variation in triglycerides, an effect which constitutes a major locus in Pimas. Our findings provide an empirical example for the concept that population-based linkage analysis, particularly in founder populations, can be useful for studies of complex traits.
